SO
Shawn Olsson (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in LENZ Therapeutics, Inc. (LENZ). The largest single filing was $261K of LENZ (10,000 sh across 2 lots, as filed), executed Nov 17 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 17 2025
Filed Nov 19 2025
Median ADV $2.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $261K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
LENZ
LENZ Therapeutics, Inc.
LENZ · 0 buys · 1 sell
1 filing
Recent filings
LENZSALE
LENZ Therapeutics, Inc.
View filing →
$261K10,000 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET